MagniProtect by Magniflex: the world's first antiviral sleep c... - 30 July 2020 16:00

FLORENCE, Italy, July 30, 2020 /PRNewswire-AsiaNet/ -- The innovative technology developed by Magniflex inhibits the persistence of bacteria and viruses on fabrics and has been specifically tested against SARS-COV-2. From Magniflex's Made in Italy research and innovation department, the first sleep...

  From The Alzheimer's Association International Conference 2020... - 30 July 2020 15:20

CHICAGO, July 30, 2020 /PRNewswire-AsiaNet/-- Risk factors for Alzheimer's dementia may be apparent as early as our teens and 20s, according to new research reported at the Alzheimer's Association International Conference(R) (AAIC(R)) ( https://c212.net/c/link/?t=0&l=en&o=2871606-1&h=40225120...

  Trobix Bio completed Series A funding by a leading Japanese/Si... - 30 July 2020 09:01

NETANYA, Israel, July 30, 2020, /PRNewswire-AsiaNet/-- Trobix Innovation Ltd. (Trobix Bio [https://www.trobixbio.com/ ]), an Israeli-based biotechnology company developing therapies to remove the threat of antimicrobial resistance, announces the closing of a US $ 3 Million Series A funding from its le...

  From The Alzheimer's Association International Conference 2020... - 30 July 2020 01:00

CHICAGO, July 30, 2020 /PRNewswire-AsiaNet/ -- COVID-19 and the global pandemic have caused significant disruption to all aspects of life including Alzheimer's clinical research worldwide. The impact of COVID, quarantine, and the resulting fear and isolation are causing problems, but also driv...

  SEKISUI Diagnostics Invests (GBP)14.4 Million in cGMP Biopharm... - 29 July 2020 23:00

BURLINGTON, Massachusetts, July 29, 2020 /PRNewswire-AsiaNet/ -- Sekisui announces the decision to invest (GBP)14.4 Million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022. This investment follows the in...

  INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA ... - 29 July 2020 21:30

PLYMOUTH MEETING, Pennsylvania, July 29, 2020 /PRNewswire-AsiaNet/ -- INOVIO (NASDAQ: INO) today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for INO-3107, its DNA medicine being evaluated in a Phase 1/2 trial for treatment of recurrent respiratory papillomatosis (RRP). ...

  Consulcesi: “Covid-19 The Virus OF Fear” An Italian Movie Rega... - 29 July 2020 20:00

ROME, July 29, 2020 /PRNewswire-AsiaNet/ -- Science and cinema: Consulcesi presents the innovative model made in Italy for continuing education in medicine and disassembling fake news "Will we be able to learn anything from all this?" The movie trailer of "Covid-19 The Virus of Fear" c...

  Celltrion Selects Movilitas for Serialization and Traceability... - 29 July 2020 11:38

COLUMBIA, Maryland, July 29, 2020 /PRNewswire-AsiaNet/ -- -- Project delivers a combined solution for end-to-end visibility in EU, Korea and U.S. markets Movilitas, a technology leader delivering the next generation of solutions and consulting services across multiple industries to advance smart suppl...

  From the Alzheimer's Association International Conference 2020... - 29 July 2020 02:30

CHICAGO, July 29, 2020 /PRNewswire-AsiaNet/ -- A simple blood test for Alzheimer's would be a great advance for individuals with -- and at risk for -- the disease, families, doctors and researchers. Logo - https://mma.prnewswire.com/media/1219566/AAIC_2020_Logo.jpg At the Alzheimer's As...

  Royal Caribbean Group names Dr. Calvin Johnson Global Head, Pu... - 28 July 2020 23:35

MIAMI, July 28, 2020 /PRNewswire-AsiaNet/ -- - Former Pennsylvania Secretary of Health to lead strategic planning and operation of global health program Royal Caribbean Group has named Dr. Calvin Johnson as Global Head, Public Health and Chief Medical Officer. In this new role, Johnson w...